Release Date: 23/03/10 08:23 Summary: Reserve and Resource Evaluation as of 31 December 2009 Price Sensitive: Yes Download Document 106.93KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%